-
EP1727817
European procedure
Extract from the Register of European Patents
EP About this file: EP1727817
| EP1727817 - AZABICYCLOOCTAN-3-ONE DERIVATIVES AND USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.08.2011 Database last updated on 01.04.2026 | Most recent event Tooltip | 05.08.2011 | No opposition filed within time limit | published on 07.09.2011 [2011/36] | Applicant(s) | For all designated states APREA AB Nobels väg 3 171 65 Solna / SE | [2010/49] |
| Former [2009/48] | For all designated states APREA AB Nobels väg 3 171 77 Stockholm / SE | ||
| Former [2006/49] | For all designated states APREA AB c/o Karolinska Innovations AB, Fogdevreten 2B S-171 77 Stockholm / SE | Inventor(s) | 01 /
WESTMAN, Jacob Alands-Västerby S-740 20 Vänge / SE | 02 /
WIMAN, Klas Majvägen 20 S-187 51 Täby / SE | 03 /
SELIVANOVA, Galina Hagalundsgatan 44 S-169 64 Solna / SE | 04 /
BYKOV, Vladimir Runslingan 37 S-187 72 Täby / SE | [2010/39] |
| Former [2006/49] | 01 /
WESTMAN, Jacob lands-Västerby S-740 20 Vänge / SE | ||
| 02 /
WIMAN, Klas Majvägen 20 S-187 51 Täby / SE | |||
| 03 /
SELIVANOVA, Galina Hagalundsgatan 44 S-169 64 Solna / SE | |||
| 04 /
BYKOV, Vladimir Runslingan 37 S-187 72 Täby / SE | Representative(s) | Allee, Harriet Eva Charlotta, et al BRANN AB P.O. Box 12246 102 26 Stockholm / SE | [N/P] |
| Former [2006/49] | Allee, Harriet Eva Charlotta, et al Dr Ludwig Brann Patentbyra AB, Box 17192 104 62 Stockholm / SE | Application number, filing date | 05722253.1 | 22.03.2005 | [2006/49] | WO2005SE00412 | Priority number, date | SE20040000708 | 22.03.2004 Original published format: SE 0400708 | [2006/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005090341 | Date: | 29.09.2005 | Language: | EN | [2005/39] | Type: | A1 Application with search report | No.: | EP1727817 | Date: | 06.12.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2005 takes the place of the publication of the European patent application. | [2006/49] | Type: | B1 Patent specification | No.: | EP1727817 | Date: | 29.09.2010 | Language: | EN | [2010/39] | Search report(s) | International search report - published on: | SE | 29.09.2005 | Classification | IPC: | C07D453/00, C07D453/02, A61K31/439, A61P35/00 | [2006/49] | CPC: |
C07D453/02 (EP,US);
A61K31/439 (EP,US);
A61P35/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/49] | Extension states | AL | 04.09.2006 | BA | 04.09.2006 | HR | 04.09.2006 | LV | 04.09.2006 | MK | 04.09.2006 | YU | 04.09.2006 | Title | German: | AZABICYCLOOCTAN-3-ONDERIVATE UND DEREN VERWENDUNG | [2006/49] | English: | AZABICYCLOOCTAN-3-ONE DERIVATIVES AND USE THEREOF | [2006/49] | French: | DERIVE D'AZABICYCLOOCTANE-3-ONE ET UTILISATION CORRESPONDANTE | [2006/49] | Entry into regional phase | 04.09.2006 | National basic fee paid | 04.09.2006 | Designation fee(s) paid | 04.09.2006 | Examination fee paid | Examination procedure | 04.09.2006 | Amendment by applicant (claims and/or description) | 04.09.2006 | Examination requested [2006/49] | 29.02.2008 | Despatch of a communication from the examining division (Time limit: M04) | 04.07.2008 | Reply to a communication from the examining division | 12.11.2009 | Cancellation of oral proceeding that was planned for 16.12.2009 | 17.11.2009 | Despatch of a communication from the examining division (Time limit: M02) | 18.11.2009 | Reply to a communication from the examining division | 16.12.2009 | Date of oral proceedings | 16.12.2009 | Date of oral proceedings (cancelled) | 13.04.2010 | Communication of intention to grant the patent | 02.08.2010 | Fee for grant paid | 02.08.2010 | Fee for publishing/printing paid | Opposition(s) | 30.06.2011 | No opposition filed within time limit [2011/36] | Fees paid | Renewal fee | 23.03.2007 | Renewal fee patent year 03 | 17.03.2008 | Renewal fee patent year 04 | 20.03.2009 | Renewal fee patent year 05 | 26.03.2010 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] CHEMICAL ABSTRACTS, vol. 108, no. 7, 1987, Columbus, Ohio, US; abstract no. 49287M, YANINA A. ET AL.: "Synthesis and pharmacological properties of 2- and 2,3-substitutd quinuclidines." page 808-811; XP002991621 [X] | [X] KHIM.-FAR. ZH., vol. 21, no. 7, 1987, USA, pages 808 - 811, XP002991621 | [X] NIELSEN A. ET AL.: "Systems with Bridgehead Nitrogen.", JOURNAL OF ORGANIC CHEMISTRY., vol. 31, no. 4, 1966, pages 1053 - 1059, XP002991622 [X] DOI: http://dx.doi.org/10.1021/jo01342a016 | [A] BONDARENKO V. ET AL.: "Synthesis and antiarrhythmic activity of derivatives of 3-aminoquinuclidine and 2-(aminomethyl).", PHARMACEUTICAL CHEMISTRY JOURNAL., vol. 12, no. 11, 1978, pages 1452 - 1455, XP002991623 [A] DOI: http://dx.doi.org/10.1007/BF00772644 | [A] VOROB'EVA V. ET AL.: "Reaction of 2-methylene-3-oxoquinuclidine with nucleophilic reagents.", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, vol. 10, 1977, pages 1098 - 1104, XP002991624 [A] DOI: http://dx.doi.org/10.1007/BF00480146 | [A] BERSTEN T. ET AL.: "Synthesis and evaluation of prima-1 and its analogs as compounds capable of restoring normal activity to mutant P-53.", AMERICAB CHEMICAL SOCIETY, vol. 7, no. 11, September 2003 (2003-09-01), NEW YORK, pages 255, XP002991625 [A] |